A detailed history of Wells Fargo & Company transactions in Avanos Medical, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 87,639 shares of AVNS stock, worth $1.79 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
87,639
Previous 85,111 2.97%
Holding current value
$1.79 Million
Previous $1.69 Million 3.01%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$17.85 - $20.42 $45,124 - $51,621
2,528 Added 2.97%
87,639 $1.75 Million
Q1 2024

May 10, 2024

BUY
$17.97 - $22.68 $169,762 - $214,257
9,447 Added 12.49%
85,111 $1.69 Million
Q4 2023

Feb 09, 2024

SELL
$17.64 - $22.99 $35,738 - $46,577
-2,026 Reduced 2.61%
75,664 $1.7 Million
Q3 2023

Nov 13, 2023

SELL
$19.93 - $26.31 $189,474 - $250,129
-9,507 Reduced 10.9%
77,690 $1.57 Million
Q2 2023

Aug 15, 2023

BUY
$22.53 - $30.98 $468,488 - $644,198
20,794 Added 31.31%
87,197 $2.23 Million
Q1 2023

May 12, 2023

BUY
$26.92 - $31.75 $393,355 - $463,931
14,612 Added 28.21%
66,403 $1.97 Million
Q4 2022

Feb 13, 2023

SELL
$19.88 - $27.37 $165,998 - $228,539
-8,350 Reduced 13.88%
51,791 $1.4 Million
Q3 2022

Nov 14, 2022

SELL
$21.56 - $29.59 $52,196 - $71,637
-2,421 Reduced 3.87%
60,141 $1.31 Million
Q2 2022

Aug 12, 2022

SELL
$24.87 - $34.68 $951,103 - $1.33 Million
-38,243 Reduced 37.94%
62,562 $1.71 Million
Q1 2022

May 16, 2022

SELL
$28.87 - $35.77 $291,413 - $361,062
-10,094 Reduced 9.1%
100,805 $3.38 Million
Q4 2021

Feb 14, 2022

SELL
$29.25 - $36.02 $277,231 - $341,397
-9,478 Reduced 7.87%
110,899 $3.85 Million
Q3 2021

Nov 15, 2021

BUY
$31.2 - $38.5 $780,093 - $962,615
25,003 Added 26.22%
120,377 $3.76 Million
Q2 2021

Aug 16, 2021

SELL
$36.37 - $45.72 $340,932 - $428,579
-9,374 Reduced 8.95%
95,374 $3.47 Million
Q1 2021

May 13, 2021

SELL
$43.5 - $53.4 $1.3 Million - $1.6 Million
-29,929 Reduced 22.22%
104,748 $4.58 Million
Q4 2020

Feb 09, 2021

SELL
$33.15 - $49.5 $219,353 - $327,541
-6,617 Reduced 4.68%
134,677 $6.18 Million
Q3 2020

Nov 05, 2020

SELL
$28.67 - $34.32 $176,521 - $211,308
-6,157 Reduced 4.18%
141,294 $4.69 Million
Q2 2020

Aug 13, 2020

SELL
$23.48 - $33.86 $11.1 Million - $16 Million
-471,364 Reduced 76.17%
147,451 $4.33 Million
Q1 2020

May 14, 2020

BUY
$20.64 - $34.41 $12.8 Million - $21.3 Million
618,815 New
618,815 $16.7 Million

Others Institutions Holding AVNS

About AVANOS MEDICAL, INC.


  • Ticker AVNS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 46,487,000
  • Market Cap $950M
  • Description
  • Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, ...
More about AVNS
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.